| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |